MorphoSys AG reports results for the quarter ended in December - Earnings Summary
MorphoSys AG MOR reported quarterly adjusted earnings of 36 cents per share for the quarter ended in December, lower than the same quarter last year, when the company reported EPS of €2.41. The mean expectation of three analysts for the quarter was for earnings of 8 cents per share. Wall Street expected results
Revenue fell 27.7% to €59.02 million from a year ago; analysts expected €62.05 million.
MorphoSys AG's reported EPS for the quarter was 36 cents.
The company reported quarterly net income of €48.27 million.
MorphoSys AG shares had risen by 83.5% this quarter.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 116.7% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
Wall Street's median 12-month price target for MorphoSys AG is $14.84
This summary was machine generated from LSEG data March 14 at 05:13 a.m. UTC. All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2023 | 0.08 | 0.36 | Beat |
Sep. 30 2023 | -1.72 | -0.87 | Beat |
Jun. 30 2023 | -1.70 | -0.54 | Beat |
Mar. 31 2023 | -0.48 | -0.33 | Beat |